TALARIS THERAPEUTICS LOUISVILLE
Talaris Therapeutics is a biotechnology company that focuses on the development of cell therapies. The company's primary aim is to improve the lives of kidney transplant recipients and patients suffering from severe autoimmune diseases. Talaris Therapeutics is known for its novel cell therapy, FCR001, which is used in the treatment of diffuse systemic diseases. The company is also exploring strategic alternatives and has implemented a restructuring plan to enhance its operations and services. Talaris Therapeutics continues to advance its novel, allogeneic cell therapy through late-stage clinical development.
TALARIS THERAPEUTICS LOUISVILLE
Social Links:
Industry:
Biotechnology
Address:
Louisville, Kentucky, United States
Country:
United States
Website Url:
http://www.talaristx.com
Total Employee:
51+
Status:
Active
Similar Organizations
AlphaThera
AlphaThera is a biotechnology industry.
Ladder Therapeutics
Ladder Therapeutics is a biotechnology research company.
Probiosys Life Sciences
Probiosys Life Sciences is a Biotechnology Research institute.
Targovax
Targovax develops active immunotherapy in the form of cancer vaccines for application in post-operation treatments.
Waimangu Ventures
Waimangu Ventures is a biotechnology research industry.
Current Employees Featured
Founder
Official Site Inspections
http://www.talaristx.com
- Host name: 104.21.112.1
- IP address: 104.21.112.1
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Talaris Therapeutics Louisville"
Kalaris Therapeutics – Your vision, our mission
Your vision, our mission. Discovery of Kalaris’ lead product, TH103, was led by scientific co-founder Dr. Napoleone Ferrara, a Lasker Award-winning scientist known for isolating the …See details»
Investor Relations | Kalaris Therapeutics
Mar 19, 2025 [email protected]. Investor Relations. Mar 25, 2025 7:47 AM EDT. Change. Volume. Today's Open. Previous Close. Today's High. Today's Low. 52 Week High. 52 Week …See details»
Management Team - kalaristx.com
Kalaris Therapeutics. Your vision, our mission. About Us; Our Science; Leadership Team; News; Contact; Home / Management TeamSee details»
CEO & Director, Kalaris
Oct 21, 2024 Kalaris Therapeutics. Your vision, our mission. About Us; Our Science; Leadership Team; Contact; Investors & Press; Home / TeamSee details»
Kalaris Announces Closing of Merger with AlloVir
Mar 18, 2025 [email protected]. Media Contacts. [email protected]. Kalaris Announces Closing of Merger with AlloVir. March 18, 2025. PDF Version. Kalaris is focused on developing …See details»
Kalaris Therapeutics - Crunchbase Company Profile & Funding
Mar 18, 2025 Kalaris Therapeutics is a clinical-stage biopharmaceutical company. Kalaris Therapeutics is a clinical-stage biopharmaceutical business committed to researching and …See details»
Org Chart Kalaris Therapeutics - The Official Board
For each of our 1,289,684 listed executives, discover their exact roles and their biographies.See details»
Kalaris and AlloVir Announce Stockholder Approval of Merger
Mar 12, 2025 Combined company expected to trade on Nasdaq under “KLRS” after closing. PALO ALTO, Calif. and LEXINGTON, Mass., March 12, 2025 (GLOBE NEWSWIRE) -- Kalaris …See details»
Team - kalaristx.com
Oct 21, 2024 Kalaris Therapeutics. Your vision, our mission. About Us; Our Science; Leadership Team; Contact; Investors & Press; Home / TeamSee details»
Kalaris Therapeutics - LinkedIn
Kalaris Therapeutics | 4,118 followers on LinkedIn. Innovative retinal therapies designed to improved patients' livesSee details»
Talaris Therapeutics - Org Chart, Teams, Culture & Jobs …
Talaris Therapeutics is a late-clinical stage biotechnology company based in Boston, MA and Louisville, KY. Talaris is developing transformative cell therapies with the potential to eliminate the burden of chronic immunosuppression for …See details»
Talaris Therapeutics, Inc. Company Profile | Wellesley, MA ...
Find company research, competitor information, contact details & financial data for Talaris Therapeutics, Inc. of Wellesley, MA. Get the latest business insights from Dun & Bradstreet.See details»
Kalaris Therapeutics, Inc. Company Information - Simply Wall St
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. …See details»
AlloVir and Kalaris Therapeutics Announce Agreement for ...
Nov 8, 2024 Kalaris is a clinical-stage biopharmaceutical company founded by Samsara BioCapital and focused on development of TH103, a novel, differentiated and potentially …See details»
AlloVir and Kalaris Therapeutics have announced a merger to …
Nov 25, 2024 Presented by Kalaris Therapeutics, available at https://kalaristx.com TH103 was invented by Dr. Napoleone Ferrara, MD, a Genentech Fellow, Professor, University of …See details»
Talaris Therapeutics - VentureRadar
Website: https://talaristx.com/ Develops innovative allogeneic hematopoietic stem cell transplantation methods for solid organ transplantation, autoimmune diseases ...See details»
Board of Directors - kalaristx.com
Kalaris Therapeutics. Your vision, our mission. About Us; Our Science; Leadership Team; News; Contact; Home / Board of DirectorsSee details»
AlloVir & Kalaris Merge for Retinal Disease Therapies | OBN
Nov 11, 2024 AlloVir and Kalaris merge to advance TH103 therapy for AMD, DME, and RVO retinal diseases.See details»
Board Chairman, Kalaris
Kalaris Therapeutics. Your vision, our mission. About Us; Our Science; Leadership Team; Contact; Investors & Press; Home / TeamSee details»
Company Overview November 2024 - kalaristx.com
1. 2. Cochrane Database of Systematic Reviews 8 (2014);3) 2024 Retinal Pharmaceuticals Market Report, Market Scope September 2024; 4) Prenner, -See details»